Arabic Arabic English English French French German German
dark

Makana Therapeutics Announces the Appointment of Dr. Kurt Dasse to its Board of Directors

 Makana Therapeutics, a subsidiary of Recombinetics Inc., a leading gene editing company with platform technology applied to biomedicine and animal agriculture, announced today the appointment of Kurt A. Dasse, Ph.D., to its Board of Directors.  Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Tips for Managing Constipation with Crohn’s Disease

Next Post

DKSH acquires Hahn Healthcare

Related Posts
Total
0
Share